title: Clinical, biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab.
abstract: Systemic lupus erythematosus (SLE) is a multiorganic autoimmune disease that affects skin, osteoarticular and kidney frequently. Rituximab showed efficacy in treatment of osteoarticular and haematological SLE, but its use has been generalised for renal disease. In our case, we showed efficacy of rituximab in SLE articular disease, showing an ultrasonographic improvement.
authors.affiliation: Reumatólogo, Servicio de Reumatología Hospital del Mar - IMAS (Barcelona) Paseo Marítimo 23-25, 08003 Barcelona, Spain. vtorrente@santpau.es
authors.forename: V
authors.initials: V
authors.lastname: Torrente-Segarra
authors.forename: Mp
authors.initials: M
authors.lastname: Lisbona-Pérez
authors.forename: D
authors.initials: D
authors.lastname: Rotes-Sala
authors.forename: S
authors.initials: S
authors.lastname: Castro-Oreiro
authors.forename: J
authors.initials: J
authors.lastname: Carbonell-Abelló
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab; D014463:Ultrasonography
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab